medicare coverage of glp-1 drugs covers GLP-1s for $50/month starting July 2026 GLP-1s and The Payer Predicament
Description
And there are side effects to consider
This finding directly contradicts other studies showing protective effects
Zepbound will be added to its formulary starting October 1
Someone with mild obesity and good GLP-1 tolerance might succeed with microdosing at $129/month
One of the biggest concerns for employers who are considering coverage may be the large potential market due to prevalence of obesity
In such cases, early failure reflects technological immaturity rather than biological irrelevance
